Ordeniza, Lexie Zane Y.
HRN: 21-35-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2022
CEFTRIAXONE 1G (VIAL)
10/18/2022
10/28/2022
IVTT
660mg
Q24
Infectious Gastroenteritis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes